Taking everything into account, PLSE scores 2 out of 10 in our fundamental rating. PLSE was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While PLSE has a great health rating, there are worries on its profitability. PLSE does not seem to be growing, but still is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -68.71% | ||
| ROE | -80.62% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 29.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.02 | ||
| Quick Ratio | 10.01 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 2 / 10 to PLSE.
ChartMill assigns a valuation rating of 0 / 10 to PULSE BIOSCIENCES INC (PLSE). This can be considered as Overvalued.
PULSE BIOSCIENCES INC (PLSE) has a profitability rating of 0 / 10.